We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Low-Cost Blood Test May Enable Screening for Increased Bleeding Risk After Injury

By LabMedica International staff writers
Posted on 11 Oct 2015
Print article
From a proof-of-concept, pre-validation study, researchers have concluded that the admission hematocrit (AH) would likely provide a reliable predictor of increased bleeding risk in pediatric trauma patients.

From their retrospective review of approximately 1,340 trauma patients, ages 0 to 17 years, researchers from the Trauma Program at Children's Hospital Los Angeles (CHLA; Los Angeles, CA, USA) have suggested that an AH could be widely implemented to identify patients who may need intervention and thus improve the course and outcome of their trauma resuscitation.

Adult trauma studies have shown that a drop in hematocrit (test for percentage of the volume of whole blood that is made up of red blood cells) can occur immediately after injury – predicting ongoing occult blood loss. To date, the use of hematocrit in triaging bleeding pediatric trauma patients had not been investigated. In examining medical records of all patients who presented to CHLA’s level-1 pediatric trauma center between 2005 and 2013, the researchers found that an AH of 35-or-less was able to identify children requiring intervention (blood transfusion, angioembolization, or operation) for bleeding, up to 67 hours after arrival.

The results showed a significant difference in AH between patients who subsequently required a transfusion and those who did not. The cutoff figure of 35-or-less had a 94% sensitivity, 77% specificity, and 99.9% negative predictive value, indicating that use of this cutoff provides a reliable screening tool.

Unintentional injury from trauma is the leading cause of death in children over one year of age. Clinical assessment of young children can be far more challenging than adults, identifying their injuries (especially intra-abdominal) and assessing blood loss in children often requires additional resources and expense. "A quick and cost-effective measure, such as AH, to identify pediatric patients who are at a high risk for bleeding could provide a critical improvement in optimizing care for children, while reducing costs," said principal investigator Christopher P. Gayer, MD, PhD, FAAP, FACS, of Trauma Attending, Division of Pediatric Surgery, CHLA.

"AH can be done rapidly in the trauma bay, is relatively inexpensive, causes minimal harm, and can aid in critical decision-making and rapid identification of occult bleeding. Our results show that a hematocrit level of less than 35% on admission predicts a greater likelihood for the need of transfusion in pediatric blunt trauma patients," said first author Jamie Golden, MD, research fellow, CHLA.

The physicians noted that while a doctor's concern in the face of clinical signs of hemorrhagic shock should always take priority over lab data, a repeat hematocrit can be quickly performed if clinically indicated. They added that their study results, conducted retrospectively at a single site, require validation in a prospective, multicenter study.

The study, by Golden J et al, was published in the October, 2015, issue of the Journal of Trauma and Acute Care Surgery.

Related Links:

Children's Hospital Los Angeles


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.